Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype.
about
AGO Recommendations for Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2013Role of postmastectomy radiotherapy in early-stage (T1-2N0-1M0) triple-negative breast cancer: a systematic review.Imaging Surveillance After Primary Breast Cancer Treatment.Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with TrastuzumabNovel therapeutic strategies in the treatment of triple-negative breast cancer.Relation between radiographic BI-RADS scores and triple negativity in patients with ductal carcinomas.Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohortsTrefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma.Characterization of Niemann-Pick Type C2 protein expression in multiple cancers using a novel NPC2 monoclonal antibodyEffect of margin width on local recurrence in triple-negative breast cancer patients treated with breast-conserving therapyEstrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvementMetastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: A pilot study.Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years).Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer.Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survivalUpdate on triple-negative breast cancer: prognosis and management strategiesGenomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells?Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells.Effect of young age, positive margins, and triple negative status on disease recurrence after breast conserving therapyBreast-conserving Surgery Rates in Breast Cancer Patients With Different Molecular Subtypes: An Observational Study Based on Surveillance, Epidemiology, and End Results (SEER) Database.Pathways to breast cancer recurrence.Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort studyComparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women.Appropriate margin for lumpectomy excision of invasive breast cancer.Diagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometryImpact of Breast Cancer Subtype Defined by Immunohistochemistry Hormone Receptor and HER2 Status on the Incidence of Immediate Postmastectomy ReconstructionPatient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors.Impact of radiation therapy on survival in patients with triple-negative breast cancer.Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer.cel-mir-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation.HER2 reduces breast cancer radiosensitivity by activating focal adhesion kinase in vitro and in vivo.Pattern of Local Recurrence and Distant Metastasis in Breast Cancer By Molecular Subtype.Post-mastectomy radiation therapy without usage of a bolus may be a reasonable option.Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418).Epidemiology and survival outcome of breast cancer in a nationwide study.Outcomes of delays in time to treatment in triple negative breast cancer.MarginProbe: intraoperative margin assessment during breast conserving surgery by using radiofrequency spectroscopy.The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis.
P2860
Q30317569-348351B6-4DCB-45FD-8FE5-05B9CD187677Q33553668-254FD73E-5856-4236-A49E-CD0B6B565FEEQ33763563-7E84453A-167B-4187-95A4-0E2E6C0F2C27Q33843810-571766BD-87E5-4B57-BF2E-0B1223FFC232Q33887682-D31F6603-A4D4-4F83-B02A-2497220DDFB3Q34167298-B2D50056-79A3-451E-A9D0-D409B7E98B8DQ34636109-9D609668-833A-43D2-BCF6-9965724266BAQ35000231-B8105757-9C53-428F-9FE6-87151AA52104Q35023240-E7BC2995-E7A6-49D8-BBBD-532CC2226B18Q35146522-AE42545E-4573-49E4-8C67-7D5B52271C75Q35184621-1849B3E7-82AB-4519-8439-499B6E815915Q35203556-4F729F8C-10E0-44BD-BB56-CB893BEBF377Q35436643-0FE3CBEE-3A77-4A6D-BC92-59A93B95D309Q35866159-7763D0E1-571D-4324-B2EB-AE7761151F00Q35905187-5845A3DA-3C26-4A48-A945-C9ACC5D43B3DQ36193393-173EE5F9-F61C-40E1-9F20-4803E8C2E589Q36311616-DEB52283-CCE4-4C55-B30E-F0693C80C712Q36438357-6DF24E60-456D-469E-8A36-6716FC37508BQ36454459-05400D25-3BF6-455F-8EB6-6E0339622315Q36473956-EC9B627E-BBC5-4008-BA91-F3F73780CCD6Q36653521-9F3555E7-5EE3-4164-87A8-F75202F3FA44Q36702139-F76EF385-DA81-46D4-8559-AFA831A44167Q36814399-DD676292-C548-4587-9E80-AB79C24F818DQ36846598-5503354B-36BC-40B6-B656-AA98C8686136Q37017435-A01700AA-AF55-4B25-A5D4-2BCBB1D5AFD5Q37082166-27BE52D9-D55D-4C91-AC01-A715498D5BFEQ37187745-3BCB1304-7CE7-4BFA-ABE0-379574754088Q37204978-B8512EB3-E5A6-4AFB-BC37-258D948E9FDDQ37315903-D93D77B7-1F2E-4050-8654-6CA325EB7DE7Q37438041-F0FC6EC8-B2B4-4C16-8509-E096E732B90BQ37467944-BB8B18C3-A41A-41E7-9FD9-77B50F0D5BC9Q37520983-E2B859E7-33A5-4C46-9909-2FB2B0265ABEQ37564374-0C31B4F7-6693-4384-8577-6BE329AE911AQ37574493-E1CA8E60-6846-4FFC-800B-979EF42B6C99Q37659252-985345D5-DEE1-4540-BDFD-B0EC6F1DD19FQ37702175-A6E73A62-AD1F-4455-8E3E-6AC58EAEC732Q37725545-BACD9007-3EBB-4409-AA32-DA792FC4D76AQ38071942-40026A14-9E66-479F-966E-332D90C2D5ECQ38106488-3F8D4DF4-1B3A-4FDD-B25D-E6BC76B85A0BQ38182847-F8CAF4BD-0E64-4D5E-8842-745703EF1E74
P2860
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Locoregional recurrence after ...... review by receptor phenotype.
@en
Locoregional recurrence after ...... review by receptor phenotype.
@nl
type
label
Locoregional recurrence after ...... review by receptor phenotype.
@en
Locoregional recurrence after ...... review by receptor phenotype.
@nl
prefLabel
Locoregional recurrence after ...... review by receptor phenotype.
@en
Locoregional recurrence after ...... review by receptor phenotype.
@nl
P2093
P2860
P1476
Locoregional recurrence after ...... review by receptor phenotype.
@en
P2093
Aoife J Lowery
Karl J Sweeney
Malcolm R Kell
Michael J Kerin
Ronan W Glynn
P2860
P2888
P304
P356
10.1007/S10549-011-1891-6
P407
P577
2011-12-07T00:00:00Z